Dalwocef CV 200mg/250mg Tablet
By Dalwocef CV
Rx
6 Tablet in a Strip

Composition
Cefixime(200mg) + Clavulanic Acid(250mg)

Manufacturer - Deltis Pharma Private Limited
Industrial Plot No 97, LA. PH-1, Phase-1 Panchkula Panchkula Panchkula HR 134113 India

Expires on or after
October, 2025

liver
When using Dalwocef CV 200mg/250mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues should consult their doctor before taking this medication. A dose adjustment of Dalwocef CV 200mg/250mg Tablet might be necessary in these cases to ensure safety and effectiveness. Make sure to seek advice from your healthcare provider to determine the best course of action.

kidney
Dalwocef CV 200mg/250mg Tablet requires caution in patients with kidney disease. Dosage adjustment may be necessary. Consult your doctor for guidance.

alcohol
Caution advised when consuming alcohol with Dalwocef CV 200mg/250mg Tablet. Consult your doctor for further guidance.

driving
Caution is advised when driving while taking Dalwocef CV 200mg/250mg Tablet as it may cause side effects like allergic reactions, dizziness, or fits, which can impair your ability to drive.

pregnancy
Dalwocef CV 200mg/250mg Tablet is generally safe to use during pregnancy based on animal studies that showed minimal adverse effects on the developing baby. Limited human studies are available.

breastfeeding
When breastfeeding, it is safe to use Dalwocef CV 200mg/250mg Tablet as it is unlikely to pass into breastmilk in harmful levels based on human studies.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹168
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025